AzTrials
AzTrials

Female Genital MutilationNCT06027281

Consequences of Female Genital Mutilation on Married Women.

An observational study of Female Genital Mutilation, run by Assiut University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

To assess psychiatric, social and sexual consequences of female genital mutilation on married women. Read more about this study

Who is it for?
Ages 18 to 50 years, women onlyHealthy volunteers can take part
Conditions the study is for
Female Genital Mutilation
What is being tested?
Hamilton depression rating scale (HDRS), Hamilton anxiety rating scale (HARS) and Mini international neuropsychiatric interview (MINI)
Type of treatment
Injection or infusion
How many people
100 participants
Where
No sites listed yet
Study dates
1 Nov 2023to 1 Aug 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Study population: Married women aged 18-50 years old.

Who may be able to join

  • Married females aged 18-50 years.

Who cannot join

  • Women who have any chronic disease as diabetes or hypertension.
  • Women who have any physical or mental handicap.
  • Women who have any psychiatric disorder prior to marriage.
  • Women who refuse participation in the study.

Trial locations and contacts

No sites are listed yet.

Wageh Abd El Nasser Hassan, PhD contact

+20 01227432194

wagehabdelnasser@yahoo.com

About this study

Official title: Psychiatric, Social and Sexual Consequences of Female Genital Mutilation on Married Women

To assess psychiatric, social and sexual consequences of female genital mutilation on married women.

Read the detailed description

World Health Organization (WHO) defined female genital mutilation (FGM) as ''all procedures that involve partial or total removal of the external female genitalia, or other injury to the female genital organs for non-medical reasons.

Many countries throughout the globe perform it: Western, Eastern, and North-Eastern Africa, particularly Egypt and Ethiopia, and in parts of Asia and the Middle East (nearly half of its cases are in Egypt and Ethiopia).

Moreover, the prevalence of girls and women with FGM/C is also rising in Western countries due to migration flows.

The adverse physical consequences of female genital mutilation/cutting (FGM/C) have been thoroughly investigated and documented. Yet, we know little about the adverse mental health consequences of the practice.

Also, few systematic reviews have addressed the impact of the practice on psycho-social well-being, and there is limited understanding of what these consequences might consist.

Throughout Egypt, many studies have been conducted to determine the pattern and prevalence of FGM, but those studied the risks of FGM and its effect on women's sexual life are scare.

Being tested
Hamilton depression rating scale (HDRS), Hamilton anxiety rating scale (HARS), Mini international neuropsychiatric interview (MINI), Minnesota Multiphasic personality Inventory (MMPI), The Symptom Check-List-90-R (SCL-90-R)
Keywords
Psychiatric, Social, Sexual, Married
Medical subject headings
Coitus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Hamilton depression rating scale (HDRS)Other

    Hamilton depression scale (HDRS) is the most commonly used instrument for assessing symptoms of depression.

  • Hamilton anxiety rating scale (HARS)Other

    Hamilton anxiety rating scale (HARS) is a 14-item clinician-rated measure of the severity of perceived anxiety symptoms.

  • Mini international neuropsychiatric interview (MINI)Other

    The Mini International Neuropsychiatric Interview (MINI) was designed as a brief structured diagnostic interview for the major psychiatric disorders in DSM-III-R, DSM-IV and DSM-5 and ICD-10.

  • Minnesota Multiphasic personality Inventory (MMPI)Other

    The Minnesota Multiphasic Personality Inventory (MMPI) is used to assess personality traits and psychopathology.

  • The Symptom Check-List-90-R (SCL-90-R)Other

    The Symptom Check-List-90-R (SCL-90-R) is a widely used psychological status symptom inventory.

  • Socioeconomic scale (A.El Gilany, A.El Wehady and M.El Wasify)Other

    An Arabic version of the socioeconomic scale consisted of four dimensions, namely, level of education, employment, total family monthly income, and lifestyle of the family.

  • The female sexual function index (FSFI)Other

    The female sexual function index is a brief multidimensional scale for assessing sexual function in women.

Study groups in NCT06027281
Study groupRoleWhat they receive
Married women who had female genital mutilationNot described
Receives: Other: Hamilton depression rating scale (HDRS); Other: Hamilton anxiety rating scale (HARS); Other: Mini international neuropsychiatric interview (MINI); Other: Minnesota Multiphasic personality Inventory (MMPI); Other: The Symptom Check-List-90-R (SCL-90-R); Other: Socioeconomic scale (A.El Gilany, A.El Wehady and M.El Wasify); Other: The female sexual function index (FSFI)
Married women who didn't have female genital mutilationNot described
Receives: Other: Hamilton depression rating scale (HDRS); Other: Hamilton anxiety rating scale (HARS); Other: Mini international neuropsychiatric interview (MINI); Other: Minnesota Multiphasic personality Inventory (MMPI); Other: The Symptom Check-List-90-R (SCL-90-R); Other: Socioeconomic scale (A.El Gilany, A.El Wehady and M.El Wasify); Other: The female sexual function index (FSFI)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Hamilton depression rating scale (HDRS)

    To determine severity of anxiety.

    Measured: From 10 to 15 minutes

  2. Hamilton anxiety rating scale (HARS)

    To determine severity of anxiety.

    Measured: From 10 to 15 minutes

  3. Screening for psychiatric symptoms.

    Mini international neuropsychiatric interview (MINI)

    Measured: From 20 to 30 minutes

  4. Screening for psychiatric symptoms.

    Minnesota Multiphasic personality Inventory (MMPI)

    Measured: From 45 to 60 minutes

  5. Determination of socioeconomic class of the family.

    Family socioeconomic status scale (revised version 2019)

    Measured: From 15 to 20 minutes

  6. Screening for female sexual dysfunction.

    The female sexual function index (FSFI)

    Measured: From 15 to 20 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Sep 2023
  2. Study start1 Nov 2023 (estimated)
  3. Primary completion1 Apr 2024 (estimated)
  4. Study completion1 Aug 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Retrospective
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06027281
Sponsor's protocol ID
Consequences of FGM
Status last verified
Sep 2023
First submitted
18 Feb 2023
Last updated
7 Sep 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Abdalla SM, Galea S. Is female genital mutilation/cutting associated with adverse mental health consequences? A systematic review of the evidence. BMJ Glob Health. 2019 Jul 15;4(4):e001553. doi: 10.1136/bmjgh-2019-001553. eCollection 2019.

    PubMed 31406589
  • O'Neill S, Pallitto C. The Consequences of Female Genital Mutilation on Psycho-Social Well-Being: A Systematic Review of Qualitative Research. Qual Health Res. 2021 Jul;31(9):1738-1750. doi: 10.1177/10497323211001862. Epub 2021 Jun 8.

    PubMed 34098783
  • Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, Ferguson D, D'Agostino R Jr. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000 Apr-Jun;26(2):191-208. doi: 10.1080/009262300278597.

    PubMed 10782451
  • Thompson E. Hamilton Rating Scale for Anxiety (HAM-A). Occup Med (Lond). 2015 Oct;65(7):601. doi: 10.1093/occmed/kqv054. No abstract available.

    PubMed 26370845
  • Williams JB. Standardizing the Hamilton Depression Rating Scale: past, present, and future. Eur Arch Psychiatry Clin Neurosci. 2001;251 Suppl 2:II6-12. doi: 10.1007/BF03035120.

    PubMed 11824839
  • Pettersson A, Modin S, Wahlstrom R, Af Winklerfelt Hammarberg S, Krakau I. The Mini-International Neuropsychiatric Interview is useful and well accepted as part of the clinical assessment for depression and anxiety in primary care: a mixed-methods study. BMC Fam Pract. 2018 Jan 24;19(1):19. doi: 10.1186/s12875-017-0674-5.

    PubMed 29368585
  • van Vliet IM, de Beurs E. [The MINI-International Neuropsychiatric Interview. A brief structured diagnostic psychiatric interview for DSM-IV en ICD-10 psychiatric disorders]. Tijdschr Psychiatr. 2007;49(6):393-7. Dutch.

    PubMed 17614093
  • Floyd AE, Gupta V. Minnesota Multiphasic Personality Inventory. 2023 Apr 24. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK557525/

    PubMed 32491457
  • Schmitz N, Hartkamp N, Kiuse J, Franke GH, Reister G, Tress W. The Symptom Check-List-90-R (SCL-90-R): a German validation study. Qual Life Res. 2000 Mar;9(2):185-93. doi: 10.1023/a:1008931926181.

    PubMed 10983482

Questions about this trial

What is this clinical trial studying?

An observational study of Female Genital Mutilation, run by Assiut University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 7 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Mariam Gamil Kamel (+20 01220133561, Mariam.20134348@med.aun.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Hamilton depression rating scale (HDRS) (time frame: From 10 to 15 minutes). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06027281, which also lists 9 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Sep 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in